Informationen:
Fehler:
ID
40078
Beschreibung
Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan; ODM derived from: https://clinicaltrials.gov/show/NCT01552954
Link
https://clinicaltrials.gov/show/NCT01552954
Stichworte
Versionen (1)
- 11.03.20 11.03.20 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
11. März 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Hypertension NCT01552954
Eligibility Hypertension NCT01552954
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Hypertension NCT01552954
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Age
Item
aged 19 years or more and 75 years or less
boolean
C0001779 (UMLS CUI [1])
Hypertensive disease | Blood pressure determination | Hypertensive disease Newly Diagnosed | Antihypertensive Agents prescribed
Item
hypertension patients: patients whose blood pressure is 140/90mmhg and over, patients is newly diagnosed with hypertension or is prescribed antihypertensive medications.
boolean
C0020538 (UMLS CUI [1])
C0005824 (UMLS CUI [2])
C0020538 (UMLS CUI [3,1])
C1518321 (UMLS CUI [3,2])
C0003364 (UMLS CUI [4,1])
C0278329 (UMLS CUI [4,2])
C0005824 (UMLS CUI [2])
C0020538 (UMLS CUI [3,1])
C1518321 (UMLS CUI [3,2])
C0003364 (UMLS CUI [4,1])
C0278329 (UMLS CUI [4,2])
Hypertensive disease | Albuminuria Spot urine sample
Item
hypertensive patients verified 2 times or more of albuminuria 30 mg/g cr or more in a spot urine sample with interval of 1 week or more in recent 6 months
boolean
C0020538 (UMLS CUI [1])
C0001925 (UMLS CUI [2,1])
C0457208 (UMLS CUI [2,2])
C0001925 (UMLS CUI [2,1])
C0457208 (UMLS CUI [2,2])
GFR estimation by MDRD
Item
estimated glomerular filtration rate (gfr) by modification of diet in renal disease (mdrd) equation 30 ml/min/1.73 m2 or more
boolean
C2170215 (UMLS CUI [1])
Informed Consent
Item
patients who give written consent to this study by oneself
boolean
C0021430 (UMLS CUI [1])
Blood pressure determination
Item
blood pressure more than 160/100 mmhg
boolean
C0005824 (UMLS CUI [1])
Pregnancy
Item
pregnant
boolean
C0032961 (UMLS CUI [1])
Serum potassium measurement
Item
serum potassium level more than 5.5 meq/l at screening period
boolean
C0302353 (UMLS CUI [1])
Malignant Neoplasms | Cerebral Infarction | Myocardial Infarction | Angina, Unstable | Percutaneous Coronary Intervention | Coronary Artery Bypass Surgery
Item
patients with malignancy, acute cerebral infarction, acute myocardial infarction, unstable angina, percutaneous coronary arterial intervention (pci), or coronary artery bypass graft (cabg) in recent 6 months
boolean
C0006826 (UMLS CUI [1])
C0007785 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C1532338 (UMLS CUI [5])
C0010055 (UMLS CUI [6])
C0007785 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C1532338 (UMLS CUI [5])
C0010055 (UMLS CUI [6])
Diabetes Mellitus
Item
patients with diabetes mellitus
boolean
C0011849 (UMLS CUI [1])
Hypersensitivity Olmesartan
Item
patients who have an allergy to olmesartan
boolean
C0020517 (UMLS CUI [1,1])
C1098320 (UMLS CUI [1,2])
C1098320 (UMLS CUI [1,2])
Study Subject Participation Status | Clinical Trial | Trial Screening
Item
patients who were involved in other clinical trial in recent 1 month or are participated in screening period
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
C1710477 (UMLS CUI [3])
C0008976 (UMLS CUI [2])
C1710477 (UMLS CUI [3])
Adrenal Cortex Hormones | Immunosuppressive Agents
Item
patients taking medication(s) of corticosteroid or immunosuppressant in a screening period
boolean
C0001617 (UMLS CUI [1])
C0021081 (UMLS CUI [2])
C0021081 (UMLS CUI [2])